Overview


According to FutureWise analysis the market for protein sequencing in 2023 is US$ 1.4 billion, and is expected to reach US$ 1.87 billion by 2031 at a CAGR of 3.70%.

The increasing focus from pharmaceutical biotechnology companies towards target-based drug development is expanding the market growth. Advancements in analytical techniques and clinical mass spectrometry are also stimulating market growth. Besides, increasing financial support from public and private organizations for proteomics coupled with technological evolution for the identification of isobaric remnants in protein sequences are positively influencing the market as well.

The protein sequencing market is bifurcated into product and service, technology, application, end-user, and region. In terms of product and service, protein sequencing services are expected to be the front runner of the market. An increasing number of sequencing procedures alongside technological advancements remains the key factor driving the demand for protein sequencing products. Reagents and consumables are also expected to show notable growth owing to the rise in the number of sequencing procedures and advancements in protein sequencing technology.
Based on technology, mass spectrometry is expected to witness high growth owing to its benefits such as identification of modified proteins and cost-efficiency. Prominent players aiming towards the launch of technologically advanced spectrometry instruments are expanding the protein sequencing market size significantly.

In terms of application, biotherapeutics is expected to control the market growth owing to rising antibiotic resistance of microbes and increasing demand for targeted drug therapy. Technological advancements alongside the benefits of protein sequencing-based methods for drug development processes are positively influencing the market as well.

Academic institutes and research centers segment are expected to control the growth of the market. Academic institutes and research centres receive hefty funding from public and private organizations for proteomic research. They provide various protein sequencing services such as Edman degradation and mass spectrometry. It also overcomes the problem of budget constraints and a lack of infrastructure. Owing to these features there has been a soaring growth of academic institutes and research centres thus propelling the market.

Based on the region, North America is the global leader of the market. Increasing expenditure and research of major biotechnology and pharmaceutical companies is driving the market growth in the region. The rising focus towards structure-based drug design alongside an increase in proteomic research is boosting the presence of the market in the region. The development of protein sequencing data analysis solutions is stimulating the growth of the market in the region.

  • Agilent Technologies, Inc.
  • Bioinformatics Solutions
  • Charles River Laboratories
  • Proteome Factory
  • Rapid Novor Inc.
  • Selvita, SGS
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.
  • Waters

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product and Service

  • Sample Preparation Products and Services
  • Protein Sequencing Products
    • Reagents and Consumables
    • Instruments
      • Mass Spectrometry Instruments
      • Edman Degradation Sequencers
    • Analysis Products/Software
  • Protein Sequencing Services

By Technology

  • Edman Degradation
  • Mass Spectrometry

By Application

  • Biotherapeutics
  • Genetic Engineering
  • Other Applications

By End User

  • Academic Institutes and Research Centers
  • Pharmaceutical and Biotechnology Companies
  • Other End Users

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with major market share
  • Tier 2 players
  • New Entrants
  • Emerging players which are growing rapidly
  • Growth Prospects
  • SWOT Analysis
  • Key Trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Protein Sequencing Market By Product and Service, By Technology, By Application, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • Evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and  Middle East and Africa
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Protein Sequencing Market Variables, Trends and Scope
    •     1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Protein Sequencing Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Protein Sequencing Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Protein Sequencing Market, By Product and Service Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Sample Preparation Products and Services
        2. Protein Sequencing Products
         2.1. Reagents and Consumables
         2.2. Instruments
          2.2.1. Mass Spectrometry Instruments
          2.2.2. Edman Degradation Sequencers
         2.3. Analysis Products/Software
        3. Protein Sequencing Services

  • 8.   Protein Sequencing Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Edman Degradation
        2. Mass Spectrometry

  • 9.   Protein Sequencing Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Biotherapeutics
        2. Genetic Engineering
        3. Other Applications

  • 10.   Protein Sequencing Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Academic Institutes and Research Centers
        2. Pharmaceutical and Biotechnology Companies
        3. Other End Users

  • 11.   North America Protein Sequencing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Protein Sequencing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Protein Sequencing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Protein Sequencing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Agilent Technologies, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Bioinformatics Solutions
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Charles River Laboratories
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Proteome Factory
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Rapid Novor Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Selvita, SGS
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Shimadzu Corporation
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Thermo Fisher Scientific Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Waters
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients